Poxel

Poxel is a research integrated pharmaceutical company that develops products for metabolic diseases.

Business Model:

Revenue: $2.2M

Employees: 51-200

Detailed Poxel Information

Geographic Data

Poxel headquarters map

Address: 259-261 Avenue Jean Jaurès

City: Lyon

State: provence-alpes-côte-d'azur

Zip: 69007

Country: FR

Financial Info

Stage:

post ipo equity

Raised Last:

$6M

Raised Total:

$109M

Metrics

3,873,125Website Global Rank

3,334Website Monthly Traffic

Twitter Followers

Description

Poxel is a dynamic biopharmaceutical company developing innovative drugs for metabolic diseases, with a focus on type 2 diabetes and non-alcoholic steatohepatitis (NASH). Based in Lyon, France, Poxel was spun out in 2009 from Merck Serono, a global leader in the field of metabolic disorders at that time. They believe that targeting cellular energy regulation pathways for the treatment of metabolic diseases, including type 2 diabetes is of critical importance as disbalances are at the root of those diseases. All three of their clinical stage pipeline programs address significant targets in the energy metabolism pathways. Imeglimin, their lead program, targets mitochondrial dysfunction, mitochondria being the power station of the cell, PXL770 activates the adenosine monophosphate-activated protein kinase (AMPK), an important energy sensor, and PXL065 (DRX-065) inhibits the mitochondrial pyruvate carrier (MPC).

Contact Phone:

Contact Email:

Poxel went public on 2/13/2015 on the PA

Listed Exchange:
PA

IPO Date:
2/13/2015

Ticker Symbol:
POXEL

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
9/2014 Series B 3 $13.5M Kreos Capital
Andera Partners
Bpifrance
Kreos Capital
Andera Partners
Bpifrance
7/2015 Post-IPO Equity $22M
8/2022 Post-IPO Debt 1 - IPF Partners
IPF Partners
8/2022 Post-IPO Equity 1 $6.1M IRIS Capital Investment
IRIS Capital Investment
7/2010 Series A 4 $21M Crédit Agricole
Andera Partners
Omnes Capital
InnoBio Fund
Crédit Agricole
Andera Partners
7/2016 Post-IPO Equity $29.3M
2/2018 Private Placement $14.9M
2/2015 IPO $30.5M
7/2015 Private Placement $32.3M
6/2016 Private Placement $26.8M
2/2015 Private Placement $4.1M
12/2012 Series B 3 $17.2M InnoBio Fund
Omnes Capital
Andera Partners
InnoBio Fund
Omnes Capital
Andera Partners
8/2022 Post-IPO Debt 1 - IPF Partners
IPF Partners
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research